Document type: drug_safety_update
There are 678 pages with document type 'drug_safety_update' in the GOV.UK search index.
Rendering apps
This document type is rendered by:
Supertypes
| Type | Group |
|---|---|
| Navigation document type | other |
| Content purpose | updates-and-alerts |
| User journey | thing |
| Search user need | government |
| Email document type | other |
| Government document type | other |
| Content Purpose Subgroup | updates_and_alerts |
| Content Purpose Supergroup | news_and_communications |
Example pages
- COVID-19 vaccines (Pfizer/BioNTech and COVID-19 Vaccine AstraZeneca): current advice
- Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- Coronavirus (COVID-19): new dedicated Yellow Card reporting site for medicines and medical devices
- SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
- Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations
- Letters and drug alerts sent to healthcare professionals in December 2020
- Erythromycin: caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
- Systemic and inhaled fluoroquinolones: small risk of heart valve regurgitation; consider other therapeutic options first in patients at risk
- Live attenuated vaccines: avoid use in those who are clinically immunosuppressed
- Off-label or unlicensed use of medicines: prescribers’ responsibilities